Publications by authors named "Guido Neidhardt"

Claim this Profile
T
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.
Kristina Klaschik, Jan Hauke, Guido Neidhardt, Christian Tränkle, Harald M Surowy

Int J Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
Irene Catucci, Ana Osorio, Brita Arver, Guido Neidhardt, Massimo Bogliolo

Genet Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
Nana Weber-Lassalle, Jan Hauke, Juliane Ramser, Lisa Richters, Eva Groß, Guido Neidhardt

Breast Cancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Guido Neidhardt

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.
Eric Hahnen, Bianca Lederer, Jan Hauke, Sibylle Loibl, Sandra Kröber, Guido Neidhardt

JAMA Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.
Guido Neidhardt, Jan Hauke, Juliane Ramser, Eva Groß, Andrea Gehrig

JAMA Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer.
Guido Neidhardt, Alexandra Becker, Jan Hauke, Judit Horváth, Nadja Bogdanova Markov

Eur J Cancer Prev· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Mutations in Triple-Negative Breast Cancer.
Eric Hahnen, Jan Hauke, Christoph Engel, Guido Neidhardt, Kerstin Rhiem

Breast Care (Basel)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families.
Gioia Schnurbein, Jan Hauke, Barbara Wappenschmidt, Nana Weber-Lassalle, Stefanie Engert, Guido Neidhardt

Breast Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis